House Page: Journal Of Thoracic Oncology
ERBB3 is an inclusion eligibility criterion in five clinical trials for non-smaller cell lung carcinoma, of which 4 are open and 1 is closed. Of the trials that include ERBB3 status and non-little cell lung carcinoma as inclusion criteria, 1...
